Astrana Health (NASDAQ:ASTH) Announces Earnings Results, Misses Expectations By $0.01 EPS

Astrana Health (NASDAQ:ASTH) posted its earnings results on Tuesday. The company reported $0.31 earnings per share for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.01), Briefing.com reports. Astrana Health had a net margin of 4.49% and a return on equity of 11.52%. The firm had revenue of $404.36 million during the quarter, compared to the consensus estimate of $413.84 million. During the same period in the prior year, the company posted $0.42 EPS. The firm’s revenue was up 19.9% compared to the same quarter last year. Astrana Health updated its FY24 guidance to $1.28 to $1.52 EPS.

Astrana Health Trading Up 0.3 %

ASTH traded up $0.11 during trading on Thursday, hitting $38.20. 5,009 shares of the company traded hands, compared to its average volume of 152,369. The company has a market cap of $2.14 billion, a P/E ratio of 28.86, a PEG ratio of 1.20 and a beta of 1.12. Astrana Health has a 1 year low of $28.86 and a 1 year high of $45.71. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.11 and a current ratio of 2.11. The stock has a 50-day moving average price of $40.24.

Wall Street Analyst Weigh In

A number of analysts have commented on ASTH shares. Jefferies Financial Group began coverage on Astrana Health in a research report on Monday, February 26th. They issued a “buy” rating and a $50.00 price target for the company. Stifel Nicolaus dropped their target price on shares of Astrana Health from $50.00 to $45.00 and set a “buy” rating for the company in a report on Wednesday. Finally, Truist Financial raised their price target on Astrana Health from $41.00 to $44.00 and gave the company a “hold” rating in a report on Friday, March 1st.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.